For research use only. Not for therapeutic Use.
Tetranor-PGDM-d6 is a deuterated analog of Tetranor-PGDM, a urinary metabolite of prostaglandin D2 (PGD2), which is involved in various physiological processes, including inflammation and allergic responses. In this compound, six hydrogen atoms are replaced with deuterium, enhancing its utility in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise detection and quantification in mass spectrometry, making it valuable for tracking metabolic pathways, studying the role of PGD2 in disease processes, and improving the accuracy of biomarker analysis.
| Catalog Number | R015928 |
| CAS Number | 1314905-92-4 |
| Synonyms | (1R,2R,3S)-2-(2-Carboxyethyl)-3-hydroxy-ε,5-dioxocyclopentaneoctanoic Acid-d6 ; 11,15-Dioxo-9α-hydroxy-2,3,4,5-tetranorprostane-1,20-dioic Acid-d6 ; [1R-(1α,2β,3β)]-2-(2-Carboxyethyl)-3-hydroxy-ε,5-dioxocyclopentaneoctanoic Acid-d6 |
| Molecular Formula | C16H18O7D6 |
| Purity | ≥95% |
| Target | Prostaglandin Receptor |
| Storage | -80°C |
| InChIKey | VNJBSPJILLFAIC-OSZDNXCMSA-N |
